The Yin and Yang of Immunomodulatory Biologics: Assessing the Delicate Balance between Benefit and Risk : Toxicologic Pathology and the Immune SystemDANILENKO, Dimitry M; HONG WANG.Toxicologic pathology. 2012, Vol 40, Num 2, pp 272-287, issn 0192-6233, 16 p.Conference Paper

Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasisFÖGER, Niko; RANGELL, Linda; DANILENKO, Dimitry M et al.Science (Washington, D.C.). 2006, Vol 313, Num 5788, pp 839-842, issn 0036-8075, 4 p.Article

Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteersZIA-AMIRHOSSEINI, Parnian; SALFI, Margaret; LEESE, Philip et al.Clinical pharmacology and therapeutics. 2006, Vol 79, Num 6, pp 558-569, issn 0009-9236, 12 p.Article

A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood b cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeysVUGMEYSTER, Yulia; SESHASAYEE, Dhaya; BEN WU et al.The American journal of pathology. 2006, Vol 168, Num 2, pp 476-489, issn 0002-9440, 14 p.Article

Genetic deletion of JAM-C reveals a role in myeloid progenitor generationPRAETOR, Asja; MCBRIDE, Jacqueline M; CHIU, Henry et al.Blood. 2009, Vol 113, Num 9, pp 1919-1928, issn 0006-4971, 10 p.Article

rHuKGF ameliorates symptoms in DSS and CD4⁺CD45RB^Hi T cell transfer mouse models of inflammatory bowel diseaseBYRNE, Fergus R; FARRELL, Catherine L; ZIEGLER, Thomas R et al.American journal of physiology. Gastrointestinal and liver physiology. 2002, Vol 45, Num 4, pp G690-G701, issn 0193-1857Article